144 related articles for article (PubMed ID: 15534620)
21. The treatment of osseous metastases of hormone-refractory prostate cancer with external beam radiotherapy and Strontium-89.
De Ruysscher D; Spaas P; Specenier P
Acta Urol Belg; 1996 Sep; 64(3):13-9. PubMed ID: 8946776
[TBL] [Abstract][Full Text] [Related]
22. Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer.
Turner SL; Gruenewald S; Spry N; Gebski V;
Br J Cancer; 2001 Feb; 84(3):297-302. PubMed ID: 11161391
[TBL] [Abstract][Full Text] [Related]
23. [Value of Clodronate in the treatment of bone metastasis].
Pouillart P; Beuzeboc P
Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
[TBL] [Abstract][Full Text] [Related]
24. Effects of high-dose ketoconazole on patients who have androgen-independent prostatic cancer.
Eichenberger T; Trachtenberg J
Can J Surg; 1989 Sep; 32(5):349-52. PubMed ID: 2475237
[TBL] [Abstract][Full Text] [Related]
25. [Parenteral disodium-clodronate in patients with rheumatoid arthritis. A two-month open clinical study].
Rovetta G; Monteforte P; Molfetta L
Minerva Med; 2001 Dec; 92(6):417-9. PubMed ID: 11740429
[TBL] [Abstract][Full Text] [Related]
26. [Drug therapy with disodium clodronate combined with radiotherapy of bone metastasis of solid tumors].
Botturi M; Zanni D; Tosi G
Radiol Med; 1990 Nov; 80(5):726-33. PubMed ID: 2148401
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
28. [Half-body irradiation. Palliative efficacy and predictive factors of response in 78 procedures].
Algara M; Valls A; Ruiz V; Jaume M; Lacruz M; Foro P
Med Clin (Barc); 1994 Jun; 103(3):85-8. PubMed ID: 8065222
[TBL] [Abstract][Full Text] [Related]
29. Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.
Kylmälä T; Taube T; Tammela TL; Risteli L; Risteli J; Elomaa I
Br J Cancer; 1997; 76(7):939-42. PubMed ID: 9328156
[TBL] [Abstract][Full Text] [Related]
30. Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture.
Rovetta G; Monteforte P; Balestra V
Drugs Exp Clin Res; 2000; 26(1):25-30. PubMed ID: 10761534
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain.
Quirijnen JM; Han SH; Zonnenberg BA; de Klerk JM; van het Schip AD; van Dijk A; ten Kroode HF; Blijham GH; van Rijk PP
J Nucl Med; 1996 Sep; 37(9):1511-5. PubMed ID: 8790203
[TBL] [Abstract][Full Text] [Related]
32. Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer.
Cresswell SM; English PJ; Hall RR; Roberts JT; Marsh MM
Br J Urol; 1995 Sep; 76(3):360-5. PubMed ID: 7551847
[TBL] [Abstract][Full Text] [Related]
33. [An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].
Poliakov PIu; Larionova NA; Bychenkov OA; Moc'kin VG
Vopr Onkol; 1999; 45(3):311-3. PubMed ID: 10443239
[TBL] [Abstract][Full Text] [Related]
34. Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain.
Magnusson P; Larsson L; Englund G; Larsson B; Strang P; Selin-Sjögren L
Clin Chem; 1998 Aug; 44(8 Pt 1):1621-8. PubMed ID: 9702948
[TBL] [Abstract][Full Text] [Related]
35. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
Moiseenko VM; Blinov NN; Semiglazov VV; Konstantinova MM; Trishkina EA
Vopr Onkol; 1998; 44(6):725-8. PubMed ID: 10087976
[TBL] [Abstract][Full Text] [Related]
36. [Palliative chemotherapy with 5 FU and CPM in cancer of the prostate with bone metastases resistant to oestrogens. A clinical trial (author's transl)].
Kuss R; Khoury S; Richard F; Fourcade R; Frantz P; Capelle JP
J Urol Nephrol (Paris); 1979; 85(10-11):649-55. PubMed ID: 94108
[TBL] [Abstract][Full Text] [Related]
37. Should bisphosphonates be standard therapy for bone pain?
Paterson AH
Support Care Cancer; 1997 May; 5(3):200-4. PubMed ID: 9176965
[TBL] [Abstract][Full Text] [Related]
38. [The effect of bisphosphonates on pain relief in patients with bone metastases: A status article based on the Cochrane analysis: "Bisphosphonates for the relief of pain secondary to bone metastasis"].
Ejlertsen B; Kristensen B
Ugeskr Laeger; 2003 May; 165(20):2089-91. PubMed ID: 12812098
[No Abstract] [Full Text] [Related]
39. Effect of concomitant administration of clodronate and estramustine phosphate on their bioavailability in patients with metastasized prostate cancer.
Kylmälä T; Castrén-Kortekangas P; Seppänen J; Ylitalo P; Tammela TL
Pharmacol Toxicol; 1996 Sep; 79(3):157-60. PubMed ID: 8884875
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of the effectiveness of treating breast cancer metastases to the bones by the "no-pain index"].
Denisov LE; Ermolaeva EV; Iarygin LM; Nikiforov AM
Vopr Onkol; 1981; 27(5):14-7. PubMed ID: 7245666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
